191.032 articles found

Characterization of gastrointestinal disorders in patients with parkinsonian syndromes.

Park H, Lee JY, Shin CM, Kim JM, Kim TJ, Kim JW.

Parkinsonism Relat Disord · 2015-02-14

DOI: 10.1016/j.parkreldis.2015.02.005PMID: 25726518

Gıdalardaki Doğal Antioksidan Bileşikler

Koca, Nuray, Karadeniz,   Feryal

Gıda, Vol. 30 No. 4 · 2015-02-13

The N-terminal residues 43 to 60 form the interface for dopamine mediated α-synuclein dimerisation.

Leong SL, Hinds MG, Connor AR, Smith DP, Illes-Toth E, Pham CL, Barnham KJ, Cappai R.

PLoS One · 2015-02-13

DOI: 10.1371/journal.pone.0116497PMID: 25679387

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease.

d'Anglemont de Tassigny X, Pascual A, López-Barneo J.

Front Neuroanat · 2015-02-13

DOI: 10.3389/fnana.2015.00010PMID: 25762899

Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.

Skalova S, Svadlakova T, Shaikh Qureshi WM, Dev K, Mokry J.

Int J Mol Sci · 2015-02-13

DOI: 10.3390/ijms16024043PMID: 25689424

Head injury and risk for Parkinson disease: results from a Danish case-control study.

Kenborg L, Rugbjerg K, Lee PC, Ravnskjær L, Christensen J, Ritz B, Lassen CF.

Neurology · 2015-02-13

DOI: 10.1212/wnl.0000000000001362PMID: 25681453

Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials.

Postuma RB, Gagnon JF, Bertrand JA, Génier Marchand D, Montplaisir JY.

Neurology · 2015-02-13

DOI: 10.1212/wnl.0000000000001364PMID: 25681454

Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome.

Boot E, Butcher NJ, van Amelsvoort TA, Lang AE, Marras C, Pondal M, Andrade DM, Fung WL, Bassett AS.

Am J Med Genet A · 2015-02-13

DOI: 10.1002/ajmg.a.36928PMID: 25684639

Letter to the editor: Parkinson's disease and early subthalamotomy.

Guridi J, Obeso JA.

J Neurosurg · 2015-02-13

DOI: 10.3171/2014.8.jns141799PMID: 25679280

Walking safety and preventing falls in Parkinson's disease.

Celik B.

Arch Phys Med Rehabil · 2015-02-13

DOI: 10.1016/j.apmr.2014.11.027PMID: 25683447

Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.

Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E, Bolliri C, Zampella Maria P, Bianchi F, Cestaro B, Pezzoli G.

Parkinsonism Relat Disord · 2015-02-13

DOI: 10.1016/j.parkreldis.2015.02.004PMID: 25707302

The safety of istradefylline for the treatment of Parkinson's disease.

Müller T.

Expert Opin Drug Saf · 2015-02-13

DOI: 10.1517/14740338.2015.1014798PMID: 25676023